Seisa Medical is a leading full-service medical device manufacturer, offering comprehensive product support from multiple facilities in North America and Europe. The company has established partnerships with top medical device firms on projects spanning from concept to production and product evolution. Leveraging its vertically integrated operations, Seisa accelerates time to market and manages costs effectively. It specializes in manufacturing FDA Class I, II, and III products, engineering product transfers between facilities, and working with diverse materials and designs. Seisa also enhances partners’ production capabilities at an optimal cost.
With over three decades of experience collaborating with some of the world’s major medical device companies, Seisa is now guided by a regulatory-focused culture with FDA registration and ISO certification, dedicated to implementing lean initiatives for cost savings and enhancements.
Founded in 1983, Seisa Group is committed to expanding its partners’ global manufacturing and development footprints while upholding consistent quality throughout its various facilities. The company received a $42.50M Debt Financing investment on 02 February 2018 from Sagard, reinforcing its position in the industry.